Últimas noticias sobre Profusa (NASDAQ:PFSA) Bolsa

Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Profusa Inc

Illinois Tool Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITW#NYSE">ITW</a>) raises FY2025 GAAP EPS guidance from $10.15-$10.55 to $10.35-$10.55 vs $10.26 analyst estimate..

News

Guidance

Illinois Tool Works Raises FY2025 GAAP EPS Guidance from $10.15-$10.55 to $10.35-$10.55 vs $10.26 Est

Biotech

General

Lilly Announces Results From Long-Term Extension Of Phase 3 TRAILBLAZER-ALZ 2 Showing Patients Treated With Kisunla Demonstrating Slowing Of Decline Continued To Grow Over Three Years

Susquehanna analyst Christopher Rolland maintains Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) with a Positive and raises the price target from $135 to $210.

Price Target

Analyst Ratings

Susquehanna Maintains Positive on Advanced Micro Devices, Raises Price Target to $210

Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFSA#NASDAQ">PFSA</a>), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry, announces its initial $1 million Bitcoin (BTC) investment under its previously reported treasury&nbsp;<a href="https://www.globenewswire.com/Tracker?data=3KuFFwgTAc5Lyke0YSrDvjXzYamCHfCEpi_Zn6QCabi_4XzzjA_YzyR9YXbkvtLVTzpwhAb0JoAhsFzhRag_p_-B6e9RZY_ZfDi06c-y5Fm-WZc01iT_T4WpOANYwp55P555ODGHLGZRHxr6MFFGitsdOiUDfNu4O2_DO6chARDj4O_6QYL_m4QwRPpZFS2AZoPU0UAB-3wOZAkAIM0Z-w==">strategy</a>. The company intends to continue to tap into the growing adoption of digital assets led by Bitcoin to hedge against macroeconomic uncertainties. Profusa has partnered with BlockFills, a leading global provider of crypto trading solutions and financial technology firm, to execute on Profusa's BTC treasury management strategy.

PFSA

Profusa Announces Initial $1M Bitcoin Investment Under Its Treasury Strategy

Capital Power (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CPX#TSX">CPX</a>) reported quarterly losses of $(0.92) per share which missed the analyst consensus estimate of $0.48 by 291.67 percent. This is a 280.39 percent decrease over earnings of $0.51 per share from the same period last year. The company reported quarterly sales of $441.000 million which missed the analyst consensus estimate of $687.690 million by 35.87 percent. This is a 43.02 percent decrease over sales of $774.000 million the same period last year.

Earnings

Earnings Misses

TSX:CPX

Capital Power Q2 EPS $(0.92) Misses $0.48 Estimate, Sales $441.000M Miss $687.690M Estimate

Federal Signal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSS#NYSE">FSS</a>) raises FY2025 Adj EPS guidance from $3.63-$3.90 to $3.92-$4.10 vs $3.82 analyst estimate. Raises FY2025 sales outlook from $2.020 billion-$2.100 billion to $2.070 billion-$2.130 billion vs $2.055 billion estimate.

Federal Signal Raises FY2025 Adj EPS Guidance from $3.63-$3.90 to $3.92-$4.10 vs $3.82 Est; Raises FY2025 Sales Guidance from $2.020B-$2.100B to $2.070B-$2.130B vs $2.055B Est

Analysts are flagging growing near-term risks from overcrowded short positions in the U.S. dollar, raising the possibility of a sharp reversal that could ripple across risk assets, <a href="https://www.benzinga.com/money/bitcoin-price-prediction">including cryptocurrencies</a>.
What Happened: According to market commentary from QCP Capital, the consensus bearish narrative on the dollar, fueled by the ongoing tariff war and expected monetary easing, may be approaching exhaustion.
"With the dollar already down 10% year-to-date and CFTC data showing extreme short positioning in USDJPY, the market appears vulnerable to a short squeeze," the firm noted. 
Such a reversal, they argue, could trigger risk-off positioning across equities, emerging markets, and crypto assets.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46699147/kuvi-ai-raises-700000-seed-round-to-launch-private-beta-of-agentic-finance-operating-system">Kuvi.ai Raises $700,000 Seed Round To Launch Private Beta Of Agentic Finance Operating System</a>
Iliya Kalchev, analyst at Nexo Dispatch, echoed the cautious tone, highlighting that the market enters midweek in a "holding pattern," with the dollar at the center of macro uncertainty ahead of major data releases and the Federal Reserve's rate decision. 
While Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) consolidates near $118,000 and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) hovers around $3,800, investors are watching for shifts in capital flows that could result from a dollar rebound.
Why It Matters: Despite supportive crypto headlines, such as record inflows into Ethereum ETFs and Strategy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) recent $2.5 billion Bitcoin purchase, analysts emphasize that markets have failed to respond meaningfully to bullish catalysts, a typical sign of near-term exhaustion.
The dollar's trajectory could be further complicated by tariff tensions, with a looming Aug. 1 deadline for new reciprocal levies announced by President Donald Trump.
Although the U.S. and EU have reached a temporary truce, trade tensions with China and other regions remain unresolved.
Macro data this week, including U.S. Q2 GDP, employment figures, and inflation indicators, will be pivotal in shaping Fed policy and market sentiment heading into the third quarter.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46697213/how-bitcoin-treasury-companies-are-beating-bitcoins-returns">How Bitcoin Treasury Companies Are Beating Bitcoin&#8217;s Returns</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

MSTR

Could The 'Short Dollar' Trade Tank Bitcoin? Analysts Say It Might—Under One Condition

Illinois Tool Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITW#NYSE">ITW</a>) reported quarterly earnings of $2.58 per share which beat the analyst consensus estimate of $2.54 by 1.45 percent. This is a 1.57 percent increase over earnings of $2.54 per share from the same period last year. The company reported quarterly sales of $4.10 billion which beat the analyst consensus estimate of $4.00 billion by 2.45 percent. This is a 1.81 percent increase over sales of $4.03 billion the same period last year.

Earnings Beats

Illinois Tool Works Q2 EPS $2.58 Beats $2.54 Estimate, Sales $4.10B Beat $4.00B Estimate

Contracts

CPI Aerostructures Receives $2.4M In Follow-on Orders For Welded Assemblies

SNBR

Sleep Number Q2 EPS $(1.09) Misses $(0.11) Estimate, Sales $327.93M Miss $357.42M Estimate

Gates Industrial Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTES#NYSE">GTES</a>) raises FY2025 Adj EPS guidance from $1.36-$1.52 to $1.44-$1.52 vs $1.44 analyst estimate..

GTES

Gates Industrial Corp Raises FY2025 Adj EPS Guidance from $1.36-$1.52 to $1.44-$1.52 vs $1.44 Est, ore sales growth in the range of +0.5% to +2.5% year-over-year

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>), a clinical-stage company focused on oncology and obesity, announced today that an abstract on updated clinical data from its Phase 1/2 clinical study conducted in the United States and Europe of CRB-701 (SYS6002) has been accepted for presentation as a poster at the <a href="https://www.globenewswire.com/Tracker?data=wDtWlZWDricLo0tJ-J_RMEg38lKIBEj5o3pgMRwF9AzV45NZJnUUTjBzS0yrlkk-_ulmAbk8JB9O2rUS2aPfI6YUwjlQZHzn3Yed2FbInP1ZHol6vs_maWAuNkuAcdxNIUdjWPmUg9oKopelTlJHvV92yb9w7zW-SD_FfQFr_fm-_puJahQc4bSOgZATlNSc">European Society for Medical Oncology</a> (ESMO) Congress 2025, to be held October 17-21, 2025 in Berlin, Germany.
The abstract, a Phase 1/2 study of the next-generation Nectin-4-targeting antibody–drug conjugate CRB-701 (SYS6002) in patients with urothelial and non-urothelial solid tumours by Perez et al, will be presented as a poster (# 967P) on Sunday, October 19 from 12:00-12:45 CEST.
The three-part Phase 1/2 study (<a href="https://www.globenewswire.com/Tracker?data=PufrRa3tl8ckOCyGkcpKBoW_6nFPDPr4zB4rqdyW0M8zfp-mNUpvH8OSO8TTBNK9Rmnt6gteVJP4FWyZ7O-e-KCq0QnTjSaILCBFGLCTgzTMUEKrQiq7TdAl0NwtsoYO8jBrIBCBb8d1nl3qZOJQXQ==">NCT06265727</a>) is evaluating the safety, pharmacokinetics and efficacy of CRB-701 in participants with advanced solid tumors associated with high Nectin-4 expression. The Part A dose escalation of the study evaluated four predetermined doses (1.8 mg/kg, 2.7 mg/kg, 3.6 mg/kg and 4.5 mg/kg Q3W) and is being followed by Part B (dose optimization) and Part C (dose expansion). Dose optimization is on-going with dosing at 2.7 mg/kg and 3.6 mg/kg cohorts in HNSCC, cervical and mUC tumors. The Company expects to complete dose optimization and identify a recommended Phase 2 dose in the fourth quarter of 2025.

CRBP

Corbus Pharmaceuticals Announces That An Abstract On Updated Clinical Data From Its Phase 1/2 Clinical Study Of CRB-701 Has Been Accepted For Presentation As A Poster At The European Society For Medical Oncology  Congress 2025,  October 17-21, 2025 In Berlin, Germany

Dragonfly Energy Holdings Corp. ("Dragonfly Energy" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFLI#NASDAQ">DFLI</a>), an industry leader in energy storage and battery technology, today announced the pricing of an underwritten public offering of 21,980,000 shares of common stock at a price to the public of $0.25 per share, for gross proceeds of approximately $5.5 million, before deducting underwriting discounts and commissions and other estimated offering expenses. All shares of common stock are being offered by Dragonfly Energy. The offering is expected to close on or about July 31, 2025, subject to the satisfaction of customary closing conditions.
Canaccord Genuity is acting as the sole bookrunner for the offering.
Dragonfly Energy intends to use the net proceeds from the offering for working capital and other general corporate purposes, including the repayment of its indebtedness in the ordinary course.

DFLI

Dragonfly Energy Sets Price For 21.98M Common Shares At $0.25/Share For $5.5M In Gross Proceeds

Truist Securities analyst Anthony Hau maintains Equity Lifestyle Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELS#NYSE">ELS</a>) with a Buy and lowers the price target from $71 to $68.

Truist Securities Maintains Buy on Equity Lifestyle Props, Lowers Price Target to $68

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Pebblebrook Hotel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEB#NYSE">PEB</a>) in the last three months.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Pebblebrook Hotel and provided 12-month price targets. The average target is $11.0, accompanied by a high estimate of $13.00 and a low estimate of $9.00. This upward trend is apparent, with the current average reflecting a 5.36% increase from the previous average price target of $10.44.
<img src="https://www.benzinga.com/files/images/story/2025/1753876925_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Pebblebrook Hotel among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Simon Yarmak</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$13.00</td>
<td>$11.75</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$12.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>James Feldman</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$10.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Gregory Miller</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$9.00</td>
<td>$10.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Pebblebrook Hotel. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Pebblebrook Hotel compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Pebblebrook Hotel's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Pebblebrook Hotel's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/PEB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Pebblebrook Hotel analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About Pebblebrook Hotel</h2>
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.
<h3>A Deep Dive into Pebblebrook Hotel's Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Pebblebrook Hotel's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 1.97%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Real Estate sector.
Net Margin: Pebblebrook Hotel's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -13.61%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Pebblebrook Hotel's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -1.63%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Pebblebrook Hotel's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.77%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Pebblebrook Hotel's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.97.
<h2>Analyst Ratings: Simplified</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Pebblebrook Hotel Through The Eyes Of 4 Analysts

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $405.0, a high estimate of $425.00, and a low estimate of $391.00. Surpassing the previous average price target of $388.33, the current average has increased by 4.29%.
<img src="https://www.benzinga.com/files/images/story/2025/1753876910_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of Visa by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$402.00</td>
<td>$386.00</td>
</tr>
<tr>
<td>Bryan Keane</td>
<td>Deutsche Bank</td>
<td>Announces</td>
<td>Buy</td>
<td>$410.00</td>
<td>-</td>
</tr>
<tr>
<td>Matthew Coad</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$397.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Rayna Kumar</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$391.00</td>
<td>$390.00</td>
</tr>
<tr>
<td>Dan Dolev</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$425.00</td>
<td>$359.00</td>
</tr>
<tr>
<td>Matthew Coad</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$400.00</td>
<td>-</td>
</tr>
<tr>
<td>Timothy Chiodo</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$405.00</td>
<td>$395.00</td>
</tr>
<tr>
<td>Trevor Williams</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$410.00</td>
<td>$400.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Visa. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Visa compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Visa's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Visa's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/V/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Visa analyst ratings.</a>
<h2>Unveiling the Story Behind Visa</h2>
Visa is the largest payment processor in the world. In fiscal 2024, it processed almost $16 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.
<h3>Understanding the Numbers: Visa's Finances</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Positive Revenue Trend: Examining Visa's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 9.33% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Visa's net margin excels beyond industry benchmarks, reaching 47.71%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Visa's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 11.99%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Visa's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.96% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Visa's debt-to-equity ratio is below the industry average at 0.55, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Visa Through The Eyes Of 8 Analysts

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is projected to reach an impressive $130,000-$150,000 by the close of 2025, according to a new analytical overview from TeraHash, signaling a potential surge for BTC-linked stocks.
What Happened: This bullish forecast, underpinned by continued institutional inflows and a stable macroeconomic environment, suggests a significant upside for companies deeply integrated into the Bitcoin ecosystem.
According to the TeraHash report, institutional capital is fundamentally transforming the mining industry, establishing a new baseline for Bitcoin&#8217;s price.
Sustained inflows from major funds like BlackRock, Fidelity, and ARK Invest have bolstered Bitcoin, which has steadily traded between $115,000 and $125,000 since June, supported by $54.6 billion in cumulative ETF inflows and increasing institutional demand.
As of July, ETF vehicles alone control over 1.26 million BTC, roughly 6% of the total supply, acting as a significant price anchor and liquidity sink. This growing base of passive holders is expected to reduce the impact of speculative cycles and lend durability to the mining revenue model.
Corporate buyers are further reinforcing this trend, with companies like Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), formerly MicroStrategy, and Japan-based Metaplanet Inc. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/MTPLF#OTCQX">MTPLF</a>) continuing to add Bitcoin to their balance sheets throughout 2025.
On-chain behavior also confirms that long-term holders are in accumulation mode, with over 14 million BTC of the circulating supply now in cold storage, leading to a more favorable supply environment with less sell-side friction for miners.
Here is a list of a few BTC-linked stocks and Bitcoin ETFs that are likely to soar if BTC prices make new records.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Bitcoin-Linked Stocks</td>
<td>YTD Performance</td>
<td>One-Year Performance</td>
</tr>
<tr>
<td>Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>)</td>
<td>31.55%</td>
<td>146.03%</td>
</tr>
<tr>
<td>MARA Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>)</td>
<td>-3.49%</td>
<td>-15.81%</td>
</tr>
<tr>
<td>Riot Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>)</td>
<td>30.02%</td>
<td>31%</td>
</tr>
<tr>
<td>Core Scientific Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>)</td>
<td>-8.91%</td>
<td>43.06%</td>
</tr>
<tr>
<td>IREN Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>)</td>
<td>50.96%</td>
<td>68.34%</td>
</tr>
<tr>
<td>CleanSpark Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>)</td>
<td>24.13%</td>
<td>-25.29%</td>
</tr>
<tr>
<td>Robinhood Markets Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>)</td>
<td>161.97%</td>
<td>406.47%</td>
</tr>
<tr>
<td>Coinbase Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>)</td>
<td>44.41%</td>
<td>65.48%</td>
</tr>
</tbody>
</table>
</figure>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Bitcoin-Linked ETFs</td>
<td>YTD Performance</td>
<td>One-Year Performance</td>
</tr>
<tr>
<td>iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>)</td>
<td>20.48%</td>
<td>77.66%</td>
</tr>
<tr>
<td>Fidelity Wise Origin Bitcoin Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/FBTC#BATS">FBTC</a>)</td>
<td>20.47%</td>
<td>77.86%</td>
</tr>
<tr>
<td>Bitwise Bitcoin ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITB#NYSE">BITB</a>)</td>
<td>20.58%</td>
<td>78%</td>
</tr>
<tr>
<td>Invesco Galaxy Bitcoin ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/BTCO#BATS">BTCO</a>)</td>
<td>20.52%</td>
<td>77.80%</td>
</tr>
<tr>
<td>Grayscale Bitcoin Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBTC#NYSE">GBTC</a>)</td>
<td>19.65%</td>
<td>75.63%</td>
</tr>
</tbody>
</table>
</figure>
See Also:&nbsp;<a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46513468/bitcoin-miner-iren-could-surge-1572-as-sotp-valuation-pegs-300-target-hedge-fund-manager-eric-jackson-says-were-cooking-with-gas" target="_blank" rel="noreferrer noopener">Bitcoin Miner IREN Could Surge 1,572% As SOTP Valuation Pegs $300 Target — Hedge Fund Manager Eric Jackson Says, ‘We're Cooking With Gas'</a>
Why It Matters: While the outlook for Bitcoin&#8217;s price is favorable, the report also delves into the competitive pressures within the mining sector.
Hashrate has surged over 30% year-to-date, driven by public mining firms rolling out next-gen ASICs (Application-Specific Integrated Circuit) and aggressively scaling operations.
This expansion, particularly from companies like Marathon Digital and Riot Platforms, is expected to push the network hashrate to approximately 1.2 ZH/s by year-end, with mining difficulty climbing towards 140T.
The rise of Hashrate-as-a-Service (HaaS) is also noted, providing institutional investors with a capital-light way to engage with mining, with the market projected to reach $6-10 billion by year-end.
Despite tightening margins for miners due to increased difficulty and energy volatility, the institutionalization of Bitcoin is transforming mining into a more stable, capital-efficient business for those who can adapt.
The report concludes that while the fundamentals remain strong, the margin for error is narrowing, emphasizing the need for precision, adaptability, and resilience in the competitive Bitcoin mining landscape of late 2025
Price Action: As of the publication of this article, BTC was trading at $117,587.82 per coin, whereas the&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and&nbsp;Invesco QQQ Trust ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher in premarket on Wednesday. The SPY was up 0.15% at $636.19, while the QQQ advanced 0.25% to $568.70, according to&nbsp;<a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>&nbsp;data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/hedge-funds/25/07/46687204/warren-buffett-has-56-of-his-258-billion-portfolios-value-exposed-to-ai-here-are-the-5-stocks-that-are-leveraging-ai-within-berkshires-holdings" target="_blank" rel="noreferrer noopener">Warren Buffett Has 56% Of His $258 Billion Portfolio's Value Exposed To AI: Here Are The 5 Stocks That Are Leveraging AI Within Berkshire's Holdings</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. 
Image Credit: Bob Montgomery / USA TODAY NETWORK Imagn Images

Bitwise Bitcoin ETF Common Shares of Beneficial Interest

BITB

Invesco Galaxy Bitcoin ETF Invesco Galaxy Bitcoin ETF

BTCO

CLSK

COIN

Core Scientific, Inc. - Class A Common Stock

CORZ

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

GBTC

HOOD

IBIT

IREN

MARA

MTPLF

RIOT

Bitcoin To Hit $150K By Year End, Says TeraHash: MSTR, MARA, RIOT, COIN And Other BTC-Linked Stocks Are Poised To Soar

Gates Industrial Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTES#NYSE">GTES</a>) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.37 by 4.56 percent. This is a 8.33 percent increase over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $883.700 million which beat the analyst consensus estimate of $873.240 million by 1.20 percent. This is a 0.20 percent decrease over sales of $885.500 million the same period last year.

Gates Industrial Corp Q2 Adj. EPS $0.39 Beats $0.37 Estimate, Sales $883.700M Beat $873.240M Estimate

Hess Midstream (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HESM#NYSE">HESM</a>) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0.59 by 25.42 percent. This is a 25.42 percent increase over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $414.200 million which beat the analyst consensus estimate of $405.081 million by 2.25 percent. This is a 13.32 percent increase over sales of $365.500 million the same period last year.

HESM

Hess Midstream Q2 EPS $0.74 Beats $0.59 Estimate, Sales $414.200M Beat $405.081M Estimate

5 analysts have expressed a variety of opinions on Wolverine World Wide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WWW#NYSE">WWW</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Wolverine World Wide, revealing an average target of $21.2, a high estimate of $30.00, and a low estimate of $17.00. This upward trend is apparent, with the current average reflecting a 19.1% increase from the previous average price target of $17.80.
<img src="https://www.benzinga.com/files/images/story/2025/1753876899_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Wolverine World Wide. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$17.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$30.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$22.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$17.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Jonathan Komp</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$20.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Wolverine World Wide. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Wolverine World Wide compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Wolverine World Wide's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Wolverine World Wide's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/WWW/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Wolverine World Wide analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know Wolverine World Wide Better</h2>
Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Corporate and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.
<h3>Wolverine World Wide's Financial Performance</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Wolverine World Wide's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 4.41%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Wolverine World Wide's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 2.62%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Wolverine World Wide's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.5% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.64%, the company showcases effective utilization of assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.77, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Profusa

Noticias

Últimas noticias sobre Profusa (NASDAQ:PFSA) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL